Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "vaccine" return 56 results.
Hatchery vaccines >
During the past 30 years the growth period of broilers decreased from 65 days to 35 days. The shortened growth period has resulted in the broiler not having enough time to develop an optimal immune re...
Vaccines >
Combining the long tradition of vaccine development of Ceva Phylaxia in Hungary and the cutting edge technology of Biomune in USA the company is committed to develop innovative vaccines that can meet...
Ceva opens new production facility in Lenexa, Kansas >
May 3, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce the May 3, 2011 opening of a new poultry vaccine production facility at its Biomune Campus in Lenexa, Kansas.
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
Ceva vector vaccine symposium now available as a web-seminar >
The highly successful vector vaccines symposium organized by Ceva this October in San Diego can now be viewed online.
Ceva conducts Global Vaccine Symposium - 2010, October 6-8th >
Do new technologies go with better poultry production and better global health ?
Ceva acquires Vetech Laboratories, Inc. >
Move adds significant poultry vaccine to innovative portfolio
Instituto Sanidad Ganadera, Argentina acquired by Ceva >
New company will build on strong biological expertise and expand Ceva’s platform in South American zone.
Joint Venture agreement between Ceva and Huadu signed in Beijing >
“Ceva Huadu” to become Innovation & R&D platform for biologicals